Healthcare -
Biotechnology - NASDAQ - US
$ 1.685
0 %
$ 10.2 M
Market Cap
-0.14
P/E
BTAI - STOCK-BASED COMPENSATION
Stock-based Compensation BTAI - BioXcel Therapeutics, Inc.
6.16 M
LAST VALUE
-40.41%
2 YEAR CAGR
14.40%
5 YEAR CAGR
0.00%
10 YEAR CAGR